IQ Consortium Member Companies
Membership in IQ is open to any corporation and/or any subsidiary thereof that is significantly engaged in the development of new chemical entities or new molecular entities for the prevention, diagnosis, or treatment of disease. For information about joining the Consortium, please see Join IQ.
Current IQ Consortium members include:
|
AbbVie Agios Alnylam Amgen, Inc. Amicus Therapeutics Astellas AstraZeneca Bayer HealthCare BeiGene Bill & Melinda Gates MRI Biogen Blueprint Medicines Boehringer Ingelheim Bristol Myers Squibb CSL Behring Daiichi Sankyo
|
Eisai, Inc. Eli Lilly and Company EMD Serono Erasca, Inc. F. Hoffmann-La Roche Genentech Gilead Sciences GSK Incyte Corporation Johnson & Johnson Merck & Co., Inc. Mitsubishi Tanabe Moderna Therapeutics Novartis Novo Nordisk
|
Organon Orion Corporation, Orion Pharma Otsuka Pfizer Regeneron Relay Therapeutics Sanofi Sarepta Servier Takeda Teva UCB Pharma Vertex, Inc. Xencor Zoetis |